Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17(11):657–674. doi:10.1038/s41571-020-0410-2
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Zhou F, et al. Nanotechnology-based photoimmunological therapies for cancer. Cancer Lett. 2019;442:429–438. doi:10.1016/j.canlet.2018.10.044
   PubMedGoogle Scholar
• Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. 2016;473(4):347–364. doi:10.1042/bj20150942
   PubMed Web of Science ®Google Scholar
• Idris NM, Jayakumar MK, Bansal A, Zhang Y. Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications. Chem Soc Rev. 2015;44(6):1449–1478. doi:10.1039/c4cs00158c
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang B, Wang H, Yuan A, Hu Y, Wu J. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics. 2018;8(18):4898–4911. doi:10.7150/thno.27598
   PubMed Web of Science ®Google Scholar
• Gao A, Chen B, Gao J, et al. Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer. Nano Lett. 2020;20(1):353–362. doi:10.1021/acs.nanolett.9b04012
   PubMedGoogle Scholar
• Zhou Z, Zhang B, Zai W, et al. Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy. Proc Natl Acad Sci U S A. 2019;116(24):11972–11977. doi:10.1073/pnas.1901987116
   PubMedGoogle Scholar
• Wang D, Wang T, Liu J, et al. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy. Nano Lett. 2016;16(9):5503–5513. doi:10.1021/acs.nanolett.6b01994
   PubMed Web of Science ®Google Scholar
• Yeung HY, Lo PC, Ng DK, Fong WP. Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model. Cell Mol Immunol. 2017;14(2):223–234. doi:10.1038/cmi.2015.84
   PubMed Web of Science ®Google Scholar
• Nam J, Son S, Park KS, Zou W, Shea LD, Moon JJ. Cancer nanomedicine for combination cancer immunotherapy. Nat Rev Mater. 2019;4(6):398–414. doi:10.1038/s41578-019-0108-1
   Web of Science ®Google Scholar
• Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3(5):380–387. doi:10.1038/nrc1071
   PubMed Web of Science ®Google Scholar
• Calixto GM, Bernegossi J, de Freitas LM, Fontana CR, Chorilli M. Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: a Review. Molecules. 2016;21(3):342. doi:10.3390/molecules21030342
   PubMed Web of Science ®Google Scholar
• Li X, Kwon N, Guo T, Liu Z, Yoon J. Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy. Angew Chem Int Ed Engl. 2018;57(36):11522–11531. doi:10.1002/anie.201805138
   PubMed Web of Science ®Google Scholar
• Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–1107. doi:10.1016/j.biopha.2018.07.049
   PubMed Web of Science ®Google Scholar
• Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–281. doi:10.3322/caac.20114
   PubMed Web of Science ®Google Scholar
• Yang G, Xu L, Chao Y, et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat Commun. 2017;8(1):902. doi:10.1038/s41467-017-01050-0
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang B, Wang S, et al. Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs. Small. 2018;14(45):e1801694. doi:10.1002/smll.201801694
   PubMedGoogle Scholar
• Chen Q, Wang X, Wang C, Feng L, Li Y, Liu Z. Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy. ACS Nano. 2015;9(5):5223–5233. doi:10.1021/acsnano.5b00640
   PubMed Web of Science ®Google Scholar
• Chen G, Jaskula-Sztul R, Esquibel CR, et al. Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging. Adv Funct Mater. 2017;27:8. doi:10.1002/adfm.201604671
   Google Scholar
• Yang G, Tian J, Chen C, et al. An oxygen self-sufficient NIR-responsive nanosystem for enhanced PDT and chemotherapy against hypoxic tumors. Chem Sci. 2019;10(22):5766–5772. doi:10.1039/c9sc00985j
   PubMed Web of Science ®Google Scholar
• Hu J, Tang Y, Elmenoufy AH, Xu H, Cheng Z, Yang X. Nanocomposite-Based Photodynamic Therapy Strategies for Deep Tumor Treatment. Small. 2015;11(44):5860–5887. doi:10.1002/smll.201501923
   PubMedGoogle Scholar
• Mishchenko T, Mitroshina E, Balalaeva I, Krysko O, Vedunova M, Krysko DV. An emerging role for nanomaterials in increasing immunogenicity of cancer cell death. Biochim Biophys Acta Rev Cancer. 2019;1871(1):99–108. doi:10.1016/j.bbcan.2018.11.004
   PubMedGoogle Scholar
• Garg AD, Krysko DV, Verfaillie T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO j. 2012;31(5):1062–1079. doi:10.1038/emboj.2011.497
   PubMed Web of Science ®Google Scholar
• Vanden Berghe T, Kalai M, Denecker G, Meeus A, Saelens X, Vandenabeele P. Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal. 2006;18(3):328–335. doi:10.1016/j.cellsig.2005.05.003
   PubMed Web of Science ®Google Scholar
• Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379. doi:10.1038/cdd.2015.158
   PubMed Web of Science ®Google Scholar
• Zhang F, Li F, Lu GH, et al. Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer. ACS Nano. 2019;13(5):5662–5673. doi:10.1021/acsnano.9b00892
   PubMed Web of Science ®Google Scholar
• Wachowska M, Muchowicz A, Demkow U. Immunological aspects of antitumor photodynamic therapy outcome. Cent Eur J Immunol. 2015;40(4):481–485. doi:10.5114/ceji.2015.56974
   PubMedGoogle Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81(1):1–5. doi:10.1189/jlb.0306164
   PubMed Web of Science ®Google Scholar
• Garg AD, Dudek AM, Agostinis P. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how? Biofactors. 2013;39(4):355–367. doi:10.1002/biof.1125
   PubMed Web of Science ®Google Scholar
• Tesniere A, Panaretakis T, Kepp O, et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 2008;15(1):3–12. doi:10.1038/sj.cdd.4402269
   PubMed Web of Science ®Google Scholar
• Alzeibak R, Mishchenko TA, Shilyagina NY, Balalaeva IV, Vedunova MV, Krysko DV. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. J Immunother Cancer. 2021;9(1). doi:10.1136/jitc-2020-001926
   PubMed Web of Science ®Google Scholar
• Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med. 2005;202(12):1691–1701. doi:10.1084/jem.20050915
   PubMed Web of Science ®Google Scholar
• Humeau J, Lévesque S, Kroemer G, Pol JG. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models. Methods Mol Biol. 2019;1884:297–315. doi:10.1007/978-1-4939-8885-3_21
   PubMedGoogle Scholar
• Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs. 1994;5(4):443–447. doi:10.1097/00001813-199408000-00009
   PubMedGoogle Scholar
• Shimizu K, Iyoda T, Okada M, Yamasaki S, Fujii SI. Immune suppression and reversal of the suppressive tumor microenvironment. Int Immunol. 2018;30(10):445–454. doi:10.1093/intimm/dxy042
   PubMed Web of Science ®Google Scholar
• Adkins I, Fucikova J, Garg AD, Agostinis P, Špíšek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology. 2014;3(12):e968434. doi:10.4161/21624011.2014.968434
   PubMed Web of Science ®Google Scholar
• Tesniere A, Schlemmer F, Boige V, et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene. 2010;29(4):482–491. doi:10.1038/onc.2009.356
   PubMed Web of Science ®Google Scholar
• Khdair A, Chen D, Patil Y, et al. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. J Control Release. 2010;141(2):137–144. doi:10.1016/j.jconrel.2009.09.004
   PubMed Web of Science ®Google Scholar
• He C, Duan X, Guo N, et al. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499. doi:10.1038/ncomms12499
   PubMed Web of Science ®Google Scholar
• Ni K, Aung T, Li S, Fatuzzo N, Liang X, Lin W. Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy. Chem. 2019;5(7):1892–1913. doi:10.1016/j.chempr.2019.05.013
   PubMedGoogle Scholar
• Chen Q, Liu L, Lu Y, et al. Tumor Microenvironment-Triggered Aggregated Magnetic Nanoparticles for Reinforced Image-Guided Immunogenic Chemotherapy. Adv Sci. 2019;6(6):1802134. doi:10.1002/advs.201802134
   Web of Science ®Google Scholar
• Kuai R, Yuan W, Son S, et al. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy. Sci Adv. 2018;4(4):eaao1736. doi:10.1126/sciadv.aao1736
   PubMed Web of Science ®Google Scholar
• Shi C, Li M, Zhang Z, et al. Catalase-based liposomal for reversing immunosuppressive tumor microenvironment and enhanced cancer chemo-photodynamic therapy. Biomaterials. 2020;233:119755. doi:10.1016/j.biomaterials.2020.119755
   PubMedGoogle Scholar
• Jin F, Qi J, Zhu M, et al. NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity. ACS Appl Mater Interfaces. 2020;12(29):32372–32387. doi:10.1021/acsami.0c07503
   PubMed Web of Science ®Google Scholar
• Liu S, Doughty A, West C, Tang Z, Zhou F, Chen WR. Determination of temperature distribution in tissue for interstitial cancer photothermal therapy. Int J Hyperthermia. 2018;34(6):756–763. doi:10.1080/02656736.2017.1370136
   PubMed Web of Science ®Google Scholar
• Sweeney EE, Cano-Mejia J, Fernandes R. Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma. Small. 2018;14(20):e1800678. doi:10.1002/smll.201800678
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Lee CT, Ashcraft KA. The future of biology in driving the field of hyperthermia. Int J Hyperthermia. 2016;32(1):4–13. doi:10.3109/02656736.2015.1091093
   PubMed Web of Science ®Google Scholar
• Yi X, Yang K, Liang C, et al. Imaging-Guided Combined Photothermal and Radiotherapy to Treat Subcutaneous and Metastatic Tumors Using Iodine-131-Doped Copper Sulfide Nanoparticles. Adv Funct Mater. 2015;25(29):4689–4699. doi:10.1002/adfm.201502003
   Web of Science ®Google Scholar
• Chu C, Lin H, Liu H, et al. Tumor Microenvironment-Triggered Supramolecular System as an In Situ Nanotheranostic Generator for Cancer Phototherapy. Adv Mater. 2017;29:23. doi:10.1002/adma.201605928
   Google Scholar
• Wang M, Rao J, Wang M, et al. Cancer photo-immunotherapy: from bench to bedside. Theranostics. 2021;11(5):2218–2231. doi:10.7150/thno.53056
   PubMed Web of Science ®Google Scholar
• Wang M, Song J, Zhou F, et al. NIR-Triggered Phototherapy and Immunotherapy via an Antigen-Capturing Nanoplatform for Metastatic Cancer Treatment. Adv Sci. 2019;6(10):1802157. doi:10.1002/advs.201802157
   Web of Science ®Google Scholar
• Verfaillie T, Garg AD, Agostinis P. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett. 2013;332(2):249–264. doi:10.1016/j.canlet.2010.07.016
   PubMed Web of Science ®Google Scholar
• Li W, Yang J, Luo L, et al. Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun. 2019;10(1):3349. doi:10.1038/s41467-019-11269-8
   PubMed Web of Science ®Google Scholar
• Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting MicroRNAs in Prostate Cancer Radiotherapy. Theranostics. 2017;7(13):3243–3259. doi:10.7150/thno.19934
   PubMedGoogle Scholar
• Golden EB, Pellicciotta I, Demaria S, Barcellos-Hoff MH, Formenti SC. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol. 2012;2:88. doi:10.3389/fonc.2012.00088
   PubMedGoogle Scholar
• Dou Y, Liu Y, Zhao F, et al. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation. Theranostics. 2018;8(21):5870–5889. doi:10.7150/thno.27351
   PubMedGoogle Scholar
• Ghoodarzi R, Changizi V, Montazerabadi AR, Eyvazzadaeh N. Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment. Lasers Med Sci. 2016;31(2):213–219. doi:10.1007/s10103-015-1844-0
   PubMed Web of Science ®Google Scholar
• Nakano A, Watanabe D, Akita Y, Kawamura T, Tamada Y, Matsumoto Y. Treatment efficiency of combining photodynamic therapy and ionizing radiation for Bowen’s disease. J Eur Acad Dermatol Venereol. 2011;25(4):475–478. doi:10.1111/j.1468-3083.2010.03757.x
   PubMedGoogle Scholar
• Lu K, He C, Guo N, et al. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy. Nat Biomed Eng. 2018;2(8):600–610. doi:10.1038/s41551-018-0203-4
   PubMed Web of Science ®Google Scholar
• Wang H, Lv B, Tang Z, et al. Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy. Nano Lett. 2018;18(9):5768–5774. doi:10.1021/acs.nanolett.8b02409
   PubMedGoogle Scholar
• Sun W, Luo L, Feng Y, et al. Aggregation-Induced Emission Gold Clustoluminogens for Enhanced Low-Dose X-ray-Induced Photodynamic Therapy. Angew Chem Int Ed Engl. 2020;59(25):9914–9921. doi:10.1002/anie.201908712
   PubMed Web of Science ®Google Scholar
• Doix B, Trempolec N, Riant O, Feron O. Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination. Front Oncol. 2019;9:811. doi:10.3389/fonc.2019.00811
   PubMed Web of Science ®Google Scholar
• Trempolec N, Doix B, Degavre C, et al. Photodynamic Therapy-Based Dendritic Cell Vaccination Suited to Treat Peritoneal Mesothelioma. Cancers. 2020;12:3. doi:10.3390/cancers12030545
   Google Scholar
• Wang Z, Cao YJ. Adoptive Cell Therapy Targeting Neoantigens: a Frontier for Cancer Research. Front Immunol. 2020;11:176. doi:10.3389/fimmu.2020.00176
   PubMed Web of Science ®Google Scholar
• Jiang X, Xu J, Liu M, et al. Adoptive CD8(+) T cell therapy against cancer: challengesand opportunities. Cancer Lett. 2019;462:23–32. doi:10.1016/j.canlet.2019.07.017
   PubMedGoogle Scholar
• Chen Q, Hu Q, Dukhovlinova E, et al. Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells. Adv Mater. 2019;31(23):e1900192. doi:10.1002/adma.201900192
   PubMed Web of Science ®Google Scholar
• Korbelik M, Sun J. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int J Cancer. 2001;93(2):269–274. doi:10.1002/ijc.1326
   PubMedGoogle Scholar
• Fang L, Zhao Z, Wang J, et al. Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed. Sci Adv. 2020;6(25):eaba4024. doi:10.1126/sciadv.aba4024
   PubMedGoogle Scholar
• Son S, Kim JH, Wang X, et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020;49(11):3244–3261. doi:10.1039/C9CS00648F
   PubMed Web of Science ®Google Scholar
• Xu M, Zhou L, Zheng L, et al. Sonodynamic therapy-derived multimodal synergistic cancer therapy. Cancer Lett. 2021;497:229–242. doi:10.1016/j.canlet.2020.10.037
   PubMed Web of Science ®Google Scholar
• Liang S, Deng X. Recent Advances in Nanomaterial-Assisted Combinational Sonodynamic Cancer Therapy. Adv Mater. 2020;32(47):2003214. doi:10.1002/adma.202003214
   Web of Science ®Google Scholar
• Zheng L, Zhang Y, Lin H, et al. Ultrasound and Near-Infrared Light Dual-Triggered Upconversion Zeolite-Based Nanocomposite for Hyperthermia-Enhanced Multimodal Melanoma Therapy via a Precise Apoptotic Mechanism. ACS Appl Mater Interfaces. 2020;12(29):32420–32431. doi:10.1021/acsami.0c07297
   PubMedGoogle Scholar
• Liu Z, Wang D, Li J, Jiang Y. Self-assembled peptido-nanomicelles as an engineered formulation for synergy-enhanced combinational SDT, PDT and chemotherapy to nasopharyngeal carcinoma. Chem Commun (Camb). 2019;55(69):10226–10229. doi:10.1039/C9CC05463D
   PubMedGoogle Scholar
• Wan Z, Sun R, Moharil P, et al. Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. J Leukoc Biol. 2021;109(2):425–436. doi:10.1002/jlb.5mr0620-063rr
   PubMed Web of Science ®Google Scholar
• Cramer GM, Moon EK, Cengel KA, Busch TM. Photodynamic Therapy and Immune Checkpoint Blockade†. Photochem Photobiol. 2020;96(5):954–961. doi:10.1111/php.13300
   PubMedGoogle Scholar
• Li M, Bolduc AR, Hoda MN, et al. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. J Immunother Cancer. 2014;2:21. doi:10.1186/2051-1426-2-21
   PubMedGoogle Scholar
• Schadendorf D, Hodi FS, Robert C, et al. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma. J Clin Oncol. 2015;33(17):1889–1894. doi:10.1200/jco.2014.56.2736
   PubMed Web of Science ®Google Scholar
• Garon EB, Rizvi NA, Hui R, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372(21):2018–2028. doi:10.1056/NEJMoa1501824
   PubMed Web of Science ®Google Scholar
• Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005;5(4):263–274. doi:10.1038/nrc1586
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281(5380):1191–1193. doi:10.1126/science.281.5380.1191
   PubMed Web of Science ®Google Scholar
• Yue EW, Douty B, Wayland B, et al. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model. J Med Chem. 2009;52(23):7364–7367. doi:10.1021/jm900518f
   PubMedGoogle Scholar
• Nayak-Kapoor A, Hao Z, Sadek R, et al. Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors. J Immunother Cancer. 2018;6(1):61. doi:10.1186/s40425-018-0351-9
   PubMed Web of Science ®Google Scholar
• Lu K, He C, Guo N, et al. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. J Am Chem Soc. 2016;138(38):12502–12510. doi:10.1021/jacs.6b06663
   PubMed Web of Science ®Google Scholar
• Liu D, Chen B, Mo Y, et al. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway. Nano Lett. 2019;19(10):6964–6976. doi:10.1021/acs.nanolett.9b02306
   PubMed Web of Science ®Google Scholar
• Zhao LP, Zheng RR, Huang JQ, et al. Self-Delivery Photo-Immune Stimulators for Photodynamic Sensitized Tumor Immunotherapy. ACS Nano. 2020. doi:10.1021/acsnano.0c06765
   Google Scholar
• Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322(5899):271–275. doi:10.1126/science.1160062
   PubMed Web of Science ®Google Scholar
• Xu J, Xu L, Wang C, et al. Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer. ACS Nano. 2017;11(5):4463–4474. doi:10.1021/acsnano.7b00715
   PubMed Web of Science ®Google Scholar
• Lin B, Liu J, Wang Y, Yang F, Huang L, Lv R. Enhanced Upconversion Luminescence-Guided Synergistic Antitumor Therapy Based on Photodynamic Therapy and Immune Checkpoint Blockade. Chem Mater. 2020;32(11):4627–4640. doi:10.1021/acs.chemmater.0c01031
   Google Scholar
• Wang Z, Zhang F, Shao D, et al. Janus Nanobullets Combine Photodynamic Therapy and Magnetic Hyperthermia to Potentiate Synergetic Anti-Metastatic Immunotherapy. Adv Sci. 2019;6(22):1901690. doi:10.1002/advs.201901690
   Web of Science ®Google Scholar
• Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8(328):328rv324. doi:10.1126/scitranslmed.aad7118
   Web of Science ®Google Scholar
• Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793–800. doi:10.1038/nm730
   PubMed Web of Science ®Google Scholar
• Duan X, Chan C, Guo N, Han W, Weichselbaum RR, Lin W. Photodynamic therapy mediated by nontoxic core-shell nanoparticles synergizes with immune checkpoint blockade to elicit antitumor immunity and antimetastatic effect on breast cancer. J Am Chem Soc. 2016;138(51):16686–16695. doi:10.1021/jacs.6b09538
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhu Z, Lv H, et al. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer. Small. 2019;15(49):e1903881. doi:10.1002/smll.201903881
   PubMed Web of Science ®Google Scholar
• Li M, Shao Y, Kim JH, et al. Unimolecular Photodynamic o2-economizer to overcome hypoxia resistance in phototherapeutics. J Am Chem Soc. 2020;142(11):5380–5388. doi:10.1021/jacs.0c00734
   PubMedGoogle Scholar
• Sun F, Zhu Q, Li T, et al. Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer. Adv Sci. 2021;8(4):2002746. doi:10.1002/advs.202002746
   Web of Science ®Google Scholar
• Xiong W, Qi L, Jiang N, et al. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. ACS Appl Mater Interfaces. 2021;13(7):8026–8041. doi:10.1021/acsami.0c21743
   PubMedGoogle Scholar
• Cha JH, Yang WH, Xia W, et al. Metformin Promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell. 2018;71(4):606–620.e607. doi:10.1016/j.molcel.2018.07.030
   PubMed Web of Science ®Google Scholar
• Ruby CE, Montler R, Zheng R, Shu S, Weinberg AD. IL-12 is required for anti-OX40-mediated CD4 T cell survival. J Immunol. 2008;180(4):2140–2148. doi:10.4049/jimmunol.180.4.2140
   PubMed Web of Science ®Google Scholar
• Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood. 2005;105(7):2845–2851. doi:10.1182/blood-2004-07-2959
   PubMed Web of Science ®Google Scholar
• Kroemer A, Xiao X, Vu MD, et al. OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J Immunol. 2007;179(8):5584–5591. doi:10.4049/jimmunol.179.8.5584
   PubMed Web of Science ®Google Scholar
• Kuang Z, Jing H, Wu Z, et al. Development and characterization of a novel anti-OX40 antibody for potent immune activation. Cancer Immunol Immunother. 2020;69(6):939–950. doi:10.1007/s00262-020-02501-2
   PubMed Web of Science ®Google Scholar
• Gough MJ, Crittenden MR, Sarff M, et al. Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. J Immunother. 2010;33(8):798–809. doi:10.1097/CJI.0b013e3181ee7095
   PubMed Web of Science ®Google Scholar
• Yokouchi H, Yamazaki K, Chamoto K, et al. Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer. Cancer Sci. 2008;99(2):361–367. doi:10.1111/j.1349-7006.2007.00664.x
   PubMed Web of Science ®Google Scholar
• Hirschhorn-Cymerman D, Rizzuto GA, Merghoub T, et al. OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. J Exp Med. 2009;206(5):1103–1116. doi:10.1084/jem.20082205
   PubMed Web of Science ®Google Scholar
• Alvim R, Nogueira L, Georgala P, et al. Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model. J Clin Oncol. 2020;38:e17004–e17004. doi:10.1200/JCO.2020.38.15_suppl.e17004
   Google Scholar
• Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity. 2016;44(5):989–1004. doi:10.1016/j.immuni.2016.05.001
   PubMed Web of Science ®Google Scholar
• de Mingo Pulido A, Gardner A, Hiebler S, et al. TIM-3 Regulates CD103(+) Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell. 2018;33(1):60–74.e66. doi:10.1016/j.ccell.2017.11.019
   PubMed Web of Science ®Google Scholar
• Kim JE, Patel MA, Mangraviti A, et al. Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas. Clin Cancer Res. 2017;23(1):124–136. doi:10.1158/1078-0432.ccr-15-1535
   PubMed Web of Science ®Google Scholar
• Anzengruber F, Avci P, de Freitas LF, Hamblin MR. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? Photochem Photobiol Sci. 2015;14(8):1492–1509. doi:10.1039/c4pp00455h
   PubMedGoogle Scholar
• Ng C, Jingchao L, Pu K. Recent progresses in phototherapy-synergized cancer immunotherapy. Adv Funct Mater. 2018;28:1804688. doi:10.1002/adfm.201804688
   Web of Science ®Google Scholar
• Wang J, Gao ZP, Qin S, Liu CB, Zou LL. Calreticulin is an effective immunologic adjuvant to tumor-associated antigens. Exp Ther Med. 2017;14(4):3399–3406. doi:10.3892/etm.2017.4989
   PubMedGoogle Scholar
• Xia Y, Gupta GK, Castano AP, Mroz P, Avci P, Hamblin MR. CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer. J Biophotonics. 2014;7(11–12):897–905. doi:10.1002/jbio.201300072
   PubMedGoogle Scholar
• Chen WR, Korbelik M, Bartels KE, Liu H, Sun J, Nordquist RE. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem Photobiol. 2005;81(1):190–195. doi:10.1562/2004-07-20-ra-236
   PubMedGoogle Scholar
• Korbelik M, Banáth J, Zhang W, et al. N-dihydrogalactochitosan as immune and direct antitumor agent amplifying the effects of photodynamic therapy and photodynamic therapy-generated vaccines. Int Immunopharmacol. 2019;75:105764. doi:10.1016/j.intimp.2019.105764
   PubMed Web of Science ®Google Scholar
• Hwang HS, Cherukula K, Bang YJ, et al. Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression. Cells. 2020;9(11). doi:10.3390/cells9112432
   Google Scholar
• Ni K, Luo T, Culbert A, Kaufmann M, Jiang X, Lin W. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy. J Am Chem Soc. 2020;142(29):12579–12584. doi:10.1021/jacs.0c05039
   PubMedGoogle Scholar
• Korbelik M, Cecic I. Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J Photochem Photobiol B. 1998;44(2):151–158. doi:10.1016/s1011-1344(98)00138-9
   PubMedGoogle Scholar
• Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24. doi:10.1038/s41577-019-0210-z
   PubMed Web of Science ®Google Scholar
• Jung NC, Kim HJ, Kang MS, et al. Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors. Cancer Lett. 2012;324(1):58–65. doi:10.1016/j.canlet.2012.04.024
   PubMedGoogle Scholar
• Zheng Y, Yin G, Le V, et al. Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy. Int J Biol Sci. 2016;12(1):120–132. doi:10.7150/ijbs.12852
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang P, Wang X, et al. Antitumor Effects of DC Vaccine With ALA-PDT-Induced immunogenic apoptotic cells for skin squamous cell carcinoma in mice. Technol Cancer Res Treat. 2018;17:1533033818785275. doi:10.1177/1533033818785275
   Web of Science ®Google Scholar
• Kleinovink JW, van Driel PB, Snoeks TJ, et al. Combination of photodynamic therapy and specific immunotherapy efficiently eradicates established tumors. Clin Cancer Res. 2016;22(6):1459–1468. doi:10.1158/1078-0432.ccr-15-0515
   PubMedGoogle Scholar
• Zheng L, Li Y, Cui Y, et al. Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies. Lasers Med Sci. 2013;28(5):1383–1392. doi:10.1007/s10103-013-1270-0
   PubMedGoogle Scholar
• Liu X, Cheng JC, Turner LS, et al. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy. Expert Opin Ther Targets. 2009;13(12):1449–1458. doi:10.1517/14728220903357512
   PubMed Web of Science ®Google Scholar
• Korbelik M, Banáth J, Zhang W, et al. Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and photodynamic therapy-generated vaccine. Int J Cancer. 2016;139(6):1372–1378. doi:10.1002/ijc.30171
   PubMed Web of Science ®Google Scholar